William Blair on Vera Therapeutics (VERA): 'We believe this update has positive read-through to companies developing novel therapies for IgAN'

Go back to William Blair on Vera Therapeutics (VERA): 'We believe this update has positive read-through to companies developing novel therapies for IgAN'
Veramark Technologies, Inc. (NASDAQ: VERA) Delayed: 31.63 +2.74 (9.48%)
Previous Close $28.89    52 Week High $1.18 
Open $31.29    52 Week Low $0.36 
Day High $32.31    P/E 527.17 
Day Low $29.73    EPS $0.06 
Volume 5,875,711